Medical News

RSS

Patients expects good long-term solutions for artificial hip system: Report

In response to the news that DePuy Orthopaedics, the manufacturer of an artificial hip system, issued a recall of its ASR product line after data indicated a higher than expected need for device replacement surgery five years after the initial procedure, Dr. Eugene S. Krauss, chairman of the Department of Orthopedics and director of the Orthopedic and Rehabilitation Institute at Glen Cove Hospital, a member of the North Shore-LIJ Health System, states,This news should not alarm anyone who has had their joint replacement performed at The Center for Joint Replacements at Glen Cove Hospital, Southside Hospital, or Peconic Bay Medical Center, as we are not using any of these components.

9 Sep 2010

Groups call for mandatory flu vaccinations for health workers

USA Today: "The American Academy of Pediatrics plans to call for all health workers to get flu vaccinations, saying unvaccinated doctors, nurses and other medical staffers pose a threat to patients. The academy, which represents 60,000 pediatricians, is the latest of several organizations that now back mandatory flu shots for health workers

9 Sep 2010

NovaBay Pharmaceuticals to deliver new data on Aganocide compounds at ICAAC Conference

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, will deliver four poster presentations on its compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

9 Sep 2010

Insulin may reduce life-threatening bacterial infections in intensive care patients

Treating intensive care patients who develop life-threatening bacterial infections, or septicemia, with insulin potentially could reduce their chances of succumbing to the infection, if results of a new preliminary study can be replicated in a larger study.

9 Sep 2010

Exostar's FIS on-demand digital credential service achieves SBCA cross-certification

Exostar, whose cloud-based solutions enable secure, cost-effective business-to-business collaboration, today announced that its Federated Identity Service (FIS) on-demand digital credential service is now fully-compliant with the SAFE-BioPharma® digital identity and signature standard.

9 Sep 2010

Micro-RNAs programmed cells can lead to malignant growth

Cancer becomes life threatening when tumor cells start leaving their primary site. They travel through the lymph and blood streams to other tissues where they grow into metastases. This transition to malignancy is associated with characteristic changes in the cancer cells. The activity of several genes is reprogrammed and, thus, the production of proteins anchoring cells to a tissue is reduced. On the other hand, the amount of surface markers which make a cancer cell mobile increases.

9 Sep 2010

Researchers discover low levels of DHA associated with chronic neurodegenerative disease

UC Irvine researchers have discovered that markedly depleted amounts of an omega-3 fatty acid in brain tissue samples from Alzheimer's patients may be due to the liver's inability to produce the complex fat, also contained in fish-oil supplements.Low levels of docosahexaenoic acid, or DHA, have been associated with the chronic neurodegenerative disease affecting millions of Americans, but no cause had been identified.

9 Sep 2010

HHS has guidance on annual limits

The Hill's Healthwatch: The Department of Health and Human Services has issued guidance on how insurers can get waivers from health law-mandated restrictions on annual limits. "The new law creates temporary restrictions on health plans starting Sept. 23. But the law also allows the annual limits to be waived 'if compliance ... would result in a significant decrease in access to benefits or a significant increase in premiums.'

9 Sep 2010

Barrier Advisors completes merger of Cornerstone Healthcare Group, Solara Healthcare

Barrier Advisors Inc., a nationally recognized middle-market restructuring, performance improvement and special situations investment banking firm, announces the completion of the merger of Cornerstone Healthcare Group and Solara Healthcare.

9 Sep 2010

CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy

Competitive Technologies, Inc. announced today the publication of the detailed results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTTC's Calmare® Pain Therapy Treatment

9 Sep 2010

Scientists discover natural mechanism to discard amyloid protein

Chemists at the University of California, San Diego, have identified how a protein that accumulates in the brains of people with Alzheimer's disease interferes with the ability of cells to get rid of debris. They also found a natural mechanism by which this protein, amyloid beta, itself may be discarded.

9 Sep 2010

NIH awards second $8 million grant for research into health effects of botanical estrogens

An ongoing research initiative into the health effects of botanical estrogens will get an $8 million boost from the National Institutes of Health.

9 Sep 2010

Team of scientists issues HIV vaccine strategy

The Council of the Global HIV Vaccine Enterprise on Tuesday released a new strategy for HIV vaccine research, which marked "the culmination of an 18-month effort that included the input of 400 scientists worldwide," VOA News reports (DeCapua, 9/7).

9 Sep 2010

Formaldehyde in clothing leads to health risk: Report

The formaldehyde added to fabrics to keep clothing looking fresh and wrinkle-free is unlikely to pose a health risk to consumers, according to an article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

9 Sep 2010

Tetraphase announces 13 data presentations on TP-434 broad spectrum antibiotic at ICAAC 2010

Tetraphase Pharmaceuticals, Inc., today announced that 12 poster presentations and an oral summary presentation on preclinical and clinical data for its lead drug candidate, TP-434, will be presented at the 2010 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA, being held September 12 -15 at the Boston Convention and Exhibition Center.

9 Sep 2010

Hemispherx Biopharma to present clinical data on XMRV retrovirus at International Workshop

Hemispherx Biopharma, Inc. will present new clinical data on the possible inter-relationships of XMRV positivity/chronic fatigue syndrome/Ampligen responsiveness at the 1st International Workshop on XMRV being held at the National Institutes of Health in Bethesda, MD, on September 7 and 8, 2010.

9 Sep 2010

ImmunoCellular Therapeutics announces long-term data from ICT-107 Phase I clinical trial for GBM

ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.

9 Sep 2010

States continue to wrestle with federal funding issues, budget shortfalls

The Fiscal Times: "Nationally, the number of Medicaid beneficiaries has risen by 8 percent a year since 2008, and 44 states have reported that they will exceed their enrollment and spending growth projections this year, the Kaiser Commission on Medicaid and the Uninsured reported. A dozen other states, including Arizona, Utah, Wisconsin and Maryland, have experienced double-digit annual enrollment increases."

9 Sep 2010

ReVision Optics completes enrollment, initial follow up in PresbyLens Phase I clinical trial for presbyopia

ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.

9 Sep 2010

Indiana State Legislators holds hearing to improve methamphetamine production

Today, the Indiana State Legislature's Criminal Law and Sentencing Policy Study Committee is holding a hearing on how the state can improve its policies for preventing the illegal diversion of pseudoephedrine (PSE) a key ingredient in leading cold and allergy medicines for methamphetamine production.

9 Sep 2010

Medical News

Patients expects good long-term solutions for artificial hip system: Report

Groups call for mandatory flu vaccinations for health workers

NovaBay Pharmaceuticals to deliver new data on Aganocide compounds at ICAAC Conference

Insulin may reduce life-threatening bacterial infections in intensive care patients

Exostar's FIS on-demand digital credential service achieves SBCA cross-certification

Micro-RNAs programmed cells can lead to malignant growth

Researchers discover low levels of DHA associated with chronic neurodegenerative disease

HHS has guidance on annual limits

Barrier Advisors completes merger of Cornerstone Healthcare Group, Solara Healthcare

CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy

Scientists discover natural mechanism to discard amyloid protein

NIH awards second $8 million grant for research into health effects of botanical estrogens

Team of scientists issues HIV vaccine strategy

Formaldehyde in clothing leads to health risk: Report

Tetraphase announces 13 data presentations on TP-434 broad spectrum antibiotic at ICAAC 2010

Hemispherx Biopharma to present clinical data on XMRV retrovirus at International Workshop

ImmunoCellular Therapeutics announces long-term data from ICT-107 Phase I clinical trial for GBM

States continue to wrestle with federal funding issues, budget shortfalls

ReVision Optics completes enrollment, initial follow up in PresbyLens Phase I clinical trial for presbyopia

Indiana State Legislators holds hearing to improve methamphetamine production

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News